Cite

HARVARD Citation

    Yuan, Y. et al. (2021). Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer. Journal of geriatric oncology. 12 (5), pp. 752-758. [Online]. 
  
Back to record